So Ra Oh
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
So Ra Oh has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Yeon Jean Cho
Department of Obstetrics and Gynecology, Samsung Jeil Women’s Clinic, Busan, Republic of Korea
2 shared publications - Geonho Lee
Department of Anesthesiology and Pain Medicine, Dong-A University Hospital, Busan, Korea
1 shared publication - Hyeongjun Lim
Department of Anesthesiology and Pain Medicine, Dong-A University Hospital, Busan, Korea
1 shared publication - Sang Yoong Park
Department of Anesthesiology and Pain Medicine, Dong-A University Hospital, Busan, Korea
1 shared publication Seung Bin Park
Department of Obstetrics and Gynecology, Dong-A University Medical Center, Dong-A University College of Medicine, Busan; Republic of Korea
1 shared publication- Seung Cheol Lee
Department of Anesthesiology and Pain Medicine, Dong-A University Hospital, Busan, Korea
1 shared publication
Latest Publications
- Open Access
- 10 November 2026
- Published by Kosin University College of Medicine in Kosin Medical Journal
=?UTF-8?B?QW5lc3RoZXRpYyBjb25zaWRlcmF0aW9ucyBmb3IgY2VzYXJlYW4gZGVsaXZlcnkgaW4gYSBwYXRpZW50IHdpdGggYSBwdWxtb25hcnkgYXJ0ZXJ5IHNsaW5nIGFuZCB0cmFjaGVhbCBzdGVub3NpczogYSBjYXNlIHJlcG9ydA==?=
Anesthetic considerations for cesarean delivery in a patient with a pulmonary artery sling and tracheal stenosis: a case report
- 10 November 2026
- Published by Kosin University College of Medicine in Kosin Medical Journal
Open Access=?UTF-8?B?QW5lc3RoZXRpYyBjb25zaWRlcmF0aW9ucyBmb3IgY2VzYXJlYW4gZGVsaXZlcnkgaW4gYSBwYXRpZW50IHdpdGggYSBwdWxtb25hcnkgYXJ0ZXJ5IHNsaW5nIGFuZCB0cmFjaGVhbCBzdGVub3NpczogYSBjYXNlIHJlcG9ydA==?=
Anesthetic considerations for cesarean delivery in a patient with a pulmonary artery sling and tracheal stenosis: a case report
- Open Access
- 1 September 2024
- Published by The Korean Society for Reproductive Medicine in Clinical and Experimental Reproductive Medicine
- Vol. 51 (3) , 247-259
p,pʹ-DDT induces apoptosis in human endometrial stromal cells via the PI3K/AKT pathway and oxidative stress
Objective: Bis-[4-chlorophenyl]-1,1,1-trichloroethane (DDT), one of the most widely used synthetic pesticides, is an endocrine-disrupting chemical with the potential to interfere with the human reproductive system. The effects of DDT and one of its metabolites, p,pʹ-DDT, on human endometrial stromal cells (ESCs) and health outcomes remain unknown. In this study, we investigated whether p,pʹ-DDT induces an imbalance in cell proliferation and apoptosis in human ESCs via oxidative stress.Methods: We assessed apoptosis in ESCs by quantifying the expression of markers associated with both intrinsic and extrinsic pathways. Additionally, we measured levels of reactive oxygen species (ROS), antioxidant enzyme activity, and estrogen receptors (ERs). We also examined changes in signaling involving nuclear factor kappa-light-chain-enhancer of activated B cells. Results: Following treatment with 1,000 pg/mL of p,pʹ-DDT, we observed an increase in Bax expression, a decrease in Bcl-2 expression, and increases in the expression of caspases 3, 6, and 8. We also noted a rise in the generation of ROS and a reduction in glutathione peroxidase expression after treatment with p,pʹ-DDT. Additionally, p,pʹ-DDT treatment led to changes in ER expression and increases in the protein levels of phosphatidylinositol 3-kinase (PI3K), phospho-protein kinase B (phospho-AKT), and phospho-extracellular signal-regulated kinase (phospho-ERK).Conclusion: p,pʹ-DDT was found to induce apoptosis in human ESCs through oxidative stress and an ER-mediated pathway. The activation of the PI3K/AKT and ERK pathways could represent potential mechanisms by which p,pʹ-DDT prompts apoptosis in human ESCs and may be linked to endometrial pathologies.
- 1 September 2024
- Published by The Korean Society for Reproductive Medicine in Clinical and Experimental Reproductive Medicine
- Vol. 51 (3) , 247-259
Open Accessp,pʹ-DDT induces apoptosis in human endometrial stromal cells via the PI3K/AKT pathway and oxidative stress
Objective: Bis-[4-chlorophenyl]-1,1,1-trichloroethane (DDT), one of the most widely used synthetic pesticides, is an endocrine-disrupting chemical with the potential to interfere with the human reproductive system. The effects of DDT and one of its metabolites, p,pʹ-DDT, on human endometrial stromal cells (ESCs) and health outcomes remain unknown. In this study, we investigated whether p,pʹ-DDT induces an imbalance in cell proliferation and apoptosis in human ESCs via oxidative stress.Methods: We assessed apoptosis in ESCs by quantifying the expression of markers associated with both intrinsic and extrinsic pathways. Additionally, we measured levels of reactive oxygen species (ROS), antioxidant enzyme activity, and estrogen receptors (ERs). We also examined changes in signaling involving nuclear factor kappa-light-chain-enhancer of activated B cells. Results: Following treatment with 1,000 pg/mL of p,pʹ-DDT, we observed an increase in Bax expression, a decrease in Bcl-2 expression, and increases in the expression of caspases 3, 6, and 8. We also noted a rise in the generation of ROS and a reduction in glutathione peroxidase expression after treatment with p,pʹ-DDT. Additionally, p,pʹ-DDT treatment led to changes in ER expression and increases in the protein levels of phosphatidylinositol 3-kinase (PI3K), phospho-protein kinase B (phospho-AKT), and phospho-extracellular signal-regulated kinase (phospho-ERK).Conclusion: p,pʹ-DDT was found to induce apoptosis in human ESCs through oxidative stress and an ER-mediated pathway. The activation of the PI3K/AKT and ERK pathways could represent potential mechanisms by which p,pʹ-DDT prompts apoptosis in human ESCs and may be linked to endometrial pathologies.
- Open Access
- 1 June 2019
- Published by The Korean Society for Reproductive Medicine in Clinical and Experimental Reproductive Medicine
- Vol. 46 (2) , 50-59
Clinical application of serum anti-Müllerian hormone in women
Anti-Müllerian hormone (AMH), a peptide growth factor of the transforming growth factor-β family, is a reliable marker of ovarian reserve. Regarding assisted reproductive technology, AMH has been efficiently used as a marker to predict ovarian response to stimulation. The clinical use of AMH has recently been extended and emphasized. The uses of AMH as a predictive marker of menopause onset, diagnostic tool for polycystic ovary syndrome, and assessment of ovarian function before and after gynecologic surgeries or gonadotoxic agents such as chemotherapy have been investigated. Serum AMH levels can also be affected by environmental and genetic factors; thus, the effects of factors that may alter AMH test results should be considered. This review summarizes the findings of recent studies focusing on the clinical application of AMH and factors that influence the AMH level and opinions on the use of the AMH level to assess the probability of conception before reproductive life planning as a "fertility test."
- 1 June 2019
- Published by The Korean Society for Reproductive Medicine in Clinical and Experimental Reproductive Medicine
- Vol. 46 (2) , 50-59
Open AccessClinical application of serum anti-Müllerian hormone in women
Anti-Müllerian hormone (AMH), a peptide growth factor of the transforming growth factor-β family, is a reliable marker of ovarian reserve. Regarding assisted reproductive technology, AMH has been efficiently used as a marker to predict ovarian response to stimulation. The clinical use of AMH has recently been extended and emphasized. The uses of AMH as a predictive marker of menopause onset, diagnostic tool for polycystic ovary syndrome, and assessment of ovarian function before and after gynecologic surgeries or gonadotoxic agents such as chemotherapy have been investigated. Serum AMH levels can also be affected by environmental and genetic factors; thus, the effects of factors that may alter AMH test results should be considered. This review summarizes the findings of recent studies focusing on the clinical application of AMH and factors that influence the AMH level and opinions on the use of the AMH level to assess the probability of conception before reproductive life planning as a "fertility test."